Improved Patient Safety Through Continuous Bi-channel RR and SpO2 Monitoring With Masimo Patient SafetyNet
SafetyNet
1 other identifier
observational
87
1 country
1
Brief Summary
The investigator intend to perform an observational study, by adding Respiratory Rate monitoring to an already existing Patient SafetyNet system with SpO2 (Oxygen Saturation) and PR (Pulse Rate) monitoring. RRa will be blinded to the clinicians and all RRa alarms will be deactivated. Retrospective analysis of the observational data collected will be utilized to evaluate the potential benefits of additional continuous respiratory rate monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2017
CompletedFirst Posted
Study publicly available on registry
February 6, 2017
CompletedStudy Start
First participant enrolled
September 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2021
CompletedMarch 2, 2026
November 1, 2025
4.1 years
January 31, 2017
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improved sensitivity of RRa by detecting the number and the incidence rate of respiratory depression events
with in 24 hours post surgery
Secondary Outcomes (1)
Time period between detection of first early symptoms of developing sepsis with RRa, PR and SpO2 monitoring compared to the first clinical diagnosis of developing sepsis.
with in 24 hours post surgery
Eligibility Criteria
patients to be admitted to the general post surgical floor who meet the inclusion and exclusion criteria will be enrolled after signing the study consent form.
You may qualify if:
- Adult 18yrs of age or older
- Post-surgical patient receiving opioid pain medication
You may not qualify if:
- Refusal of optical finger sensor and/or acoustic respiratory rate neck sensor placement
- Finger or skin abnormalities at sensor sites
- Expected opioid therapy duration less than 24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baylor Research Institutelead
- Masimo Corporationcollaborator
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2017
First Posted
February 6, 2017
Study Start
September 19, 2017
Primary Completion
November 10, 2021
Study Completion
November 10, 2021
Last Updated
March 2, 2026
Record last verified: 2025-11